 MediciNova, Inc NASDAQ: MNOV shares soared 111 in the regular and after-hours sessions on Tuesday. What Happened: The biopharmaceutical company announced a partnership with the Biomedical Advanced Research and Development Authority BARDA to repurpose MN-166 ibudilast as a potential medical countermeasure against lung damage induced by chlorine gas. 